HEOR News Roundup

Tuesday, August 13, 2019 | Issue 464

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

ICER: Zolgensma Review Not
Compromised by Data Issue

ICER said recent issues with animal testing data for Novartis’ Zolgensma will not require an updated review of the initial assessment.

Read More

Analyst: Congress Likely to Pass Drug Pricing Bill Ahead of 2020 Election


AstraZeneca to Use Inovalon’s ONE Platform for New Initiative


PCORI Awards Grant to HFA


ICER Holds Public Meeting on DMD Treatments

 

   Conference

 

340B Manufacturer Summit

August 20-21 | Alexandria, Virginia

 

   Webinar

 

From Big Data to Rapid Analytics for Rheumatology - Data Quality, Tools, and Usage

August 14

 
 
Syndicated Reports
   
Biosimilars: US Payer Insights (2019)
 
Review of Influence: The Institute for Clinical and Economic Review
 
White Papers
   
Leveraging Technology to Reduce Costs in Clinical Trials
 
Evidence Generation and Communication
 
 
  Market Access Writer 1
(Entry Level) London
Entry-Level Market Access Communications Writer Associate Director/Lead Market Access Writer Lead Market Access Writer
 
 
 
 
 

Share this newsletter!